[HTML][HTML] Progress on Ras/MAPK signaling research and targeting in blood and solid cancers

M Dillon, A Lopez, E Lin, D Sales, R Perets, P Jain - Cancers, 2021 - mdpi.com
Simple Summary The Ras-Raf-MEK-ERK signaling pathway is responsible for regulating
cell proliferation, differentiation, and survival. Overexpression and overactivation of …

[HTML][HTML] Advances in preventive vaccine development against HTLV-1 infection: A systematic review of the last 35 years

CS Santana, FO Andrade, GCS da Silva… - Frontiers in …, 2023 - frontiersin.org
Introduction The Human T-lymphotropic virus type 1 (HTLV-1) was the first described human
retrovirus. It is currently estimated that around 5 to 10 million people worldwide are infected …

Voluntary driven exoskeleton as a new tool for rehabilitation in chronic spinal cord injury: a pilot study

M Aach, O Cruciger, M Sczesny-Kaiser, O Höffken… - The Spine Journal, 2014 - Elsevier
Background context Treadmill training after traumatic spinal cord injury (SCI) has become an
established therapy to improve walking capabilities. The hybrid assistive limb (HAL) …

[HTML][HTML] MEF-2 isoforms'(AD) roles in development and tumorigenesis

K Madugula, R Mulherkar, ZK Khan, DGI Chigbu… - Oncotarget, 2019 - ncbi.nlm.nih.gov
Abstract Myocyte enhancer factor (MEF)-2 plays a critical role in proliferation, differentiation,
and development of various cell types in a tissue specific manner. Four isoforms of MEF-2 …

[HTML][HTML] The prevalence of human T-lymphotropic virus infection among blood donors in Southeast China, 2004-2013

J Xie, S Ge, Y Zhang, Y Lin, H Ni… - PLoS neglected …, 2015 - journals.plos.org
Background The human T-lymphotropic virus type 1 (HTLV-1) which is associated with the
diseases of adult T-cell leukemia/lymphoma, HTLV-1 associated myelopathy/tropical spastic …

In vivo and in vitro immunogenicity of novel MHC class I presented epitopes to confer protective immunity against chronic HTLV-1 infection

R Mulherkar, A Karabudak, R Ginwala, X Huang… - Vaccine, 2018 - Elsevier
Human T-cell leukemia virus type 1 (HTLV-1) has infected as many as 10 million people
worldwide. While 90% are asymptomatic, 5% develop severe diseases including adult T-cell …

Human acute and chronic viruses: Host-pathogen interactions and therapeutics

M Hoffman, DGI Chigbu, BL Crumley, R Sharma… - Advanced concepts in …, 2020 - Springer
Viruses are obligate intracellular pathogens that cause infection in susceptible host cells.
Virus infections could be lytic, chronic, latent or immortalizing. Viruses causing latent …

Neuroimmunological aspects of human T cell leukemia virus type 1-associated myelopathy/tropical spastic paraparesis

M Saito - Journal of neurovirology, 2014 - Springer
Human T cell leukemia virus type 1 (HTLV-1) is a replicationcompetent human retrovirus
associated with two distinct types of disease: a malignancy of mature CD4+ T cells called …

[HTML][HTML] Apigenin improves cytotoxicity of antiretroviral drugs against HTLV-1 infected cells through the modulation of ahr signaling

D Sales, E Lin, V Stoffel, S Dickson… - NeuroImmune …, 2023 - degruyter.com
Abstract Objectives HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP)
is a neuroinflammatory autoimmune disease characterized by high levels of infected …

Polymorphisms in HLA-C and KIR alleles are not associated with HAM/TSP risk in HTLV-1-infected subjects

T Assone, FM Malta, S Bakkour, L Montalvo, AM Paiva… - Virus research, 2018 - Elsevier
Introduction Several genetic polymorphisms may be related to susceptibility or resistance to
viral disease outcomes. Immunological or genetic factors may act as major triggers of the …